Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.41 USD | +0.23% | +128.50% | +83.75% |
May. 02 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
May. 02 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2024 * | 1.02B | Sales 2025 * | 1.14B | Capitalization | 231M |
---|---|---|---|---|---|
Net income 2024 * | -155M | Net income 2025 * | -110M | EV / Sales 2024 * | 0.34 x |
Net Debt 2024 * | 111M | Net Debt 2025 * | 336M | EV / Sales 2025 * | 0.5 x |
P/E ratio 2024 * |
-1.47
x | P/E ratio 2025 * |
-2.09
x | Employees | 1,600 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.65% |
Latest transcript on Emergent BioSolutions Inc.
1 day | +0.23% | ||
1 week | +128.50% | ||
Current month | +134.57% | ||
1 month | +90.09% | ||
3 months | +162.50% | ||
6 months | +99.55% | ||
Current year | +83.75% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Papa
CEO | Chief Executive Officer | 68 | Feb. 20 |
Richard Lindahl
DFI | Director of Finance/CFO | 70 | 18-03-25 |
Kelly Warfield
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 22-03-31 |
Marvin White
BRD | Director/Board Member | 61 | 10-05-31 |
Louis Sullivan
BRD | Director/Board Member | 90 | 04-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 0 M€ | -3.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 4.41 | +0.23% | 6,600,286 |
24-05-07 | 4.4 | +10.55% | 6,231,951 |
24-05-06 | 3.98 | +2.31% | 9,390,579 |
24-05-03 | 3.89 | +17.88% | 19,249,903 |
24-05-02 | 3.3 | +70.98% | 151,504,993 |
Delayed Quote Nyse, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+83.75% | 231M | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.74% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- EBS Stock